SCIENTIFIC PROJECT MANAGER
ABG-95411 | Job | Confirmed |
2021-01-11 | Other contract type | Salaire à négocier |

- Chemistry
- Health, human and veterinary medicine
Employer
OTR3 (Organes, Tissus, Régénération, Réparation et Remplacement) is a French Biotech, located in Paris, which develops RGTA®, a proprietary range of first in class products for human and veterinary purposes. Based on robust scientific background, the RGTA® technology is a breakthrough innovation with a huge potential in the field of regenerative medicine.
The company focuses on product development from fundamental research up to the market authorization stage.
OTR3 has already two wound healing products on the market for skin and corneal ulcers. More products are in development and are expected to be marketed in the coming years, addressing other indications. OTR3 has several ongoing academic and industrial partnerships, as well as a strong R&D focus.
OTR3 employs a highly motivated and qualified team
Website :
Position and assignments
The Scientific program manager will be in charge of physicochemical studies of RGTA® (modified sugars), including synthesis optimization, supervision and control of subcontracted GMP synthesis and regulatory documents. The Scientific program manager will also be in charge of the research program on new RGTA® family polysaccharides.
The Scientific program manager will also be responsible for product analysis and quality control, and will participate in research studies on the mode of action of RGTA® in vitro and in vivo, with a focus on tissue regeneration including in neurodegenerative models.
The Scientific program manager will follow up and participate in several collaboration programs with industry or academia, write reports and grant proposals, write scientific and medical communications.
Geographic mobility:
Profile
Engineer/PhD/pharmacist background with:
- High level expertise in chemistry,
- Experience in the analytical methods of polymers,
- Preferably an experience in drug development (evaluation with In vitro and in vivo models, regulatory environment, etc).
The candidate will have a strong experience in responding to research grants, and will have published papers in scientific and/or medical journals.
Native English language is an advantage, and in any case a high level of English literacy is required.
The candidate will preferably have an Animal experiment qualification (level 1)
Depending on the candidate’s experience CDI or CDD Position that may open to CDI
Goals
to be defined